[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 77, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 278234, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.28, "open": 2.26, "dayLow": 2.0, "dayHigh": 2.26, "regularMarketPreviousClose": 2.28, "regularMarketOpen": 2.26, "regularMarketDayLow": 2.0, "regularMarketDayHigh": 2.26, "payoutRatio": 0.0, "beta": 1.305, "forwardPE": -0.23654568, "volume": 26375, "regularMarketVolume": 26375, "averageVolume": 11475, "averageVolume10days": 9680, "averageDailyVolume10Day": 9680, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 2738468, "fiftyTwoWeekLow": 2.0, "fiftyTwoWeekHigh": 6.217, "fiftyDayAverage": 2.84626, "twoHundredDayAverage": 3.26365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -13935826, "profitMargins": 0.0, "floatShares": 1380698, "sharesOutstanding": 1355610, "sharesShort": 19283, "sharesShortPriorMonth": 29806, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.014199999, "heldPercentInsiders": 0.01901, "heldPercentInstitutions": 0.01055, "shortRatio": 4.76, "shortPercentOfFloat": 0.0143, "impliedSharesOutstanding": 1501260, "bookValue": 4.321, "priceToBook": 0.46750754, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13558458, "trailingEps": -10.99, "forwardEps": -8.54, "lastSplitFactor": "1:25", "lastSplitDate": 1712275200, "enterpriseToEbitda": 2.048, "52WeekChange": -0.6252319, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 2.0201, "recommendationKey": "none", "totalCash": 17656220, "totalCashPerShare": 12.704, "ebitda": -6805152, "totalDebt": 0, "quickRatio": 17.408, "currentRatio": 17.472, "returnOnAssets": -0.17429, "returnOnEquity": -0.78914, "freeCashflow": -7001793, "operatingCashflow": -4883988, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNPX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_268943522", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Synaptogenix, Inc.", "regularMarketChangePercent": -11.3991165, "regularMarketPrice": 2.0201, "corporateActions": [], "regularMarketTime": 1743796800, "marketState": "CLOSED", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 11475, "fiftyTwoWeekLowChange": 0.020100117, "fiftyTwoWeekLowChangePercent": 0.010050058, "fiftyTwoWeekRange": "2.0 - 6.217", "fiftyTwoWeekHighChange": -4.1969, "fiftyTwoWeekHighChangePercent": -0.6750683, "fiftyTwoWeekChangePercent": -62.523193, "epsTrailingTwelveMonths": -10.99, "epsForward": -8.54, "fiftyDayAverageChange": -0.82615995, "fiftyDayAverageChangePercent": -0.2902616, "twoHundredDayAverageChange": -1.2435498, "twoHundredDayAverageChangePercent": -0.38103038, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-07", "cryptoTradeable": false, "longName": "Synaptogenix, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607437800000, "regularMarketChange": -0.25989985, "regularMarketDayRange": "2.0 - 2.26", "displayName": "Synaptogenix", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]